Neutropenia Clinical Trials

Arizona Center for Cancer Care
Glendale Arizona 85306

Patients are needed to participate in a clinical research study evaluating HM10460A (45 μg/kg), HM10460A (135 μg/kg), HM10460A (270 μg/kg) and Pegfilgrastim 6mg for the treatment of Neutropenia

Desert Springs Cancer Care
Scottsdale Arizona 85255

Patients are needed to participate in a clinical research study evaluating HM10460A (45 μg/kg), HM10460A (135 μg/kg), HM10460A (270 μg/kg) and Pegfilgrastim 6mg for the treatment of Neutropenia

California Cancer Associates for Research and Excellence
Fresno California 93720

Patients are needed to participate in a clinical research study evaluating HM10460A (45 μg/kg), HM10460A (135 μg/kg), HM10460A (270 μg/kg) and Pegfilgrastim 6mg for the treatment of Neutropenia

Beaver Medical Group
Highland California 92346

Patients are needed to participate in a clinical research study evaluating HM10460A (45 μg/kg), HM10460A (135 μg/kg), HM10460A (270 μg/kg) and Pegfilgrastim 6mg for the treatment of Neutropenia

California Cancer Associates for Research and Excellence
Los Angeles California 92025

Patients are needed to participate in a clinical research study evaluating HM10460A (45 μg/kg), HM10460A (135 μg/kg), HM10460A (270 μg/kg) and Pegfilgrastim 6mg for the treatment of Neutropenia

North County Oncology
Oceanside California 92056

Patients are needed to participate in a clinical research study evaluating HM10460A (45 μg/kg), HM10460A (135 μg/kg), HM10460A (270 μg/kg) and Pegfilgrastim 6mg for the treatment of Neutropenia

Hematology Oncology Medical Group
Orange California 92868

Patients are needed to participate in a clinical research study evaluating HM10460A (45 μg/kg), HM10460A (135 μg/kg), HM10460A (270 μg/kg) and Pegfilgrastim 6mg for the treatment of Neutropenia

University Cancer Institute
Boynton Beach Florida 33426

Patients are needed to participate in a clinical research study evaluating HM10460A (45 μg/kg), HM10460A (135 μg/kg), HM10460A (270 μg/kg) and Pegfilgrastim 6mg for the treatment of Neutropenia

Research- Hen/Onc Associates of the Treasure Coast
Port St. Lucie Florida 34952

Patients are needed to participate in a clinical research study of PledOx (2 µmol/kg), PledOx (10 µmol/kg) and Placebo (0,9% NaCl) to evaluate Advanced Metastatic (Stage IV) Colorectal Cancer

Northeast Georgia Cancer Care, LLC
Athens Georgia 30607

Patients are needed to participate in a clinical research study evaluating HM10460A (45 μg/kg), HM10460A (135 μg/kg), HM10460A (270 μg/kg) and Pegfilgrastim 6mg for the treatment of Neutropenia

Kentucky Cancer Clinic
Hazard Kentucky 41701

Patients are needed to participate in a clinical research study evaluating HM10460A (45 μg/kg), HM10460A (135 μg/kg), HM10460A (270 μg/kg) and Pegfilgrastim 6mg for the treatment of Neutropenia

National Institutes of Health Clinical Center, 9000 Rockville Pike
Bethesda Maryland 20892

Patients are needed to participate in a clinical research study of Clofarabine and Lenalidomide

Memorial Sloan-Kettering Cancer Center
New York New York 10065

A Phase 4 clinical study for patients with Acute Myelogenous Leukemia or Myelodysplastic Syndrome

University of Rochester Medical Center
Rochester New York 14642

A Phase 3 clinical study for patients with Febrile Neutropenia

Good Samaritan Hospital, Corvallis
Corvallis Oregon 97330

Patients are needed to participate in a clinical research study evaluating HM10460A (45 μg/kg), HM10460A (135 μg/kg), HM10460A (270 μg/kg) and Pegfilgrastim 6mg for the treatment of Neutropenia

Associates in Oncology & Hematology
Chattanooga Tennessee 37421

Patients are needed to participate in a clinical research study of PledOx (2 µmol/kg), PledOx (10 µmol/kg) and Placebo (0,9% NaCl) to evaluate Advanced Metastatic (Stage IV) Colorectal Cancer

The University of Texas, Health Science Center at San Antonio
San Antonio Texas 78229

Patients are needed to participate in a clinical research study of PledOx (2 µmol/kg), PledOx (10 µmol/kg) and Placebo (0,9% NaCl) to evaluate Advanced Metastatic (Stage IV) Colorectal Cancer

Research Site
Bendigo Victoria 3550

A clinical trial seeking patients for a research study for the treatment of Chemotherapy-induced Febrile Neutropenia

Research Site
Shepparton Victoria 3630

A clinical trial seeking patients for a research study for the treatment of Chemotherapy-induced Febrile Neutropenia

Research Site
Tweed Heads New South Wales 2485

A clinical trial seeking patients for a research study for the treatment of Chemotherapy-induced Febrile Neutropenia

Research Site
Wodonga Victoria 3690

A clinical trial seeking patients for a research study for the treatment of Chemotherapy-induced Febrile Neutropenia

Research Site
Eggenburg 3730

A clinical trial seeking patients for a research study for the treatment of Chemotherapy-induced Febrile Neutropenia

Research Site
Graz 8036

A clinical trial seeking patients for a research study for the treatment of Chemotherapy-induced Febrile Neutropenia

Research Site
Vöcklabruck 4840

A clinical trial seeking patients for a research study for the treatment of Chemotherapy-induced Febrile Neutropenia

Research Site
Wien 1030

A clinical trial seeking patients for a research study for the treatment of Chemotherapy-induced Febrile Neutropenia

Research Site
Wien 1090

A clinical trial seeking patients for a research study for the treatment of Chemotherapy-induced Febrile Neutropenia

Investigational Site Number 004
Curitiba 81520-060
Updated

A clinical research study of CABAZITAXEL (XRP6258), Prednisone, Ciprofloxacin and G-CSF (Granulocyte colony-stimulating factor) for the treatment of Prostate Cancer

Investigational Site Number 006
Lajeado 95900-000
Updated

A clinical research study of CABAZITAXEL (XRP6258), Prednisone, Ciprofloxacin and G-CSF (Granulocyte colony-stimulating factor) for the treatment of Prostate Cancer

Investigational Site Number 005
Porto Alegre 90035-903
Updated

A clinical research study of CABAZITAXEL (XRP6258), Prednisone, Ciprofloxacin and G-CSF (Granulocyte colony-stimulating factor) for the treatment of Prostate Cancer

Investigational Site Number 001
Santo Andre 09050-360
Updated

A clinical research study of CABAZITAXEL (XRP6258), Prednisone, Ciprofloxacin and G-CSF (Granulocyte colony-stimulating factor) for the treatment of Prostate Cancer

Investigational Site Number 002
São Paulo 01321-001
Updated

A clinical research study of CABAZITAXEL (XRP6258), Prednisone, Ciprofloxacin and G-CSF (Granulocyte colony-stimulating factor) for the treatment of Prostate Cancer

Research Site
Moncton New Brunswick E1C 6Z8

A clinical trial seeking patients for a research study for the treatment of Chemotherapy-induced Febrile Neutropenia

Research Site
Montreal Quebec H2W 1T8

A clinical trial seeking patients for a research study for the treatment of Chemotherapy-induced Febrile Neutropenia

Research Site
Sault Ste. Marie Ontario P6B 0A8

A clinical trial seeking patients for a research study for the treatment of Chemotherapy-induced Febrile Neutropenia

Cancer Institute and Hospital, CAMS
Beijing

A clinical research study of pegfilgrastim,30mcg/kg, pegfilgrastim, 60mcg/kg, pegfilgrastim, 100mcg/kg and filgrastim, 5mcg/kg for the treatment of Neutropenia

Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Beijing Beijing 100021

Patients are needed to participate in a clinical research study evaluating Pegfilgrastim for the treatment of Neutropenia

Beijing Cancer Hospital
Beijing 100142

Patients are needed to participate in a clinical research study of rHSA/GCSF to evaluate Underdose (Unintentional), Cancer or Tumor

Shanghai Pulmonary Hospital
Shanghai Shanghai 200433

A Phase 3 clinical study for patients with NSCLC, Neutropenia or Febrile Neutropenia

Nemocnice Znojmo
Znojmo 66902

Multi-level Evaluation of Chemotherapy-induced Febrile Neutropenia Prophylaxis, Outcomes, and Determinants With Granulocyte-colony Stimulating Factor

Research Site
Alès Cédex 30103

A clinical trial seeking patients for a research study for the treatment of Chemotherapy-induced Febrile Neutropenia

Research Site
Arras 62000

A clinical trial seeking patients for a research study for the treatment of Chemotherapy-induced Febrile Neutropenia

Research Site
Besançon Cedex 25030

A clinical trial seeking patients for a research study for the treatment of Chemotherapy-induced Febrile Neutropenia

Research Site
Brest Cedex 2 29609

A clinical trial seeking patients for a research study for the treatment of Chemotherapy-induced Febrile Neutropenia

Research Site
Créteil 94010

A clinical trial seeking patients for a research study for the treatment of Chemotherapy-induced Febrile Neutropenia